A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal ...
Introduction Mitoxantrone is a synthetic anthracenedione cytotoxic agent with broad-spectrum anti-tumor activity against breast cancer, acute leukemia, and non-Hodgkin’s lymphoma, which is also approved as a disease-modifying treatment for multiple …